Novavax Scores FDA Approval for Nuvaxovid™ COVID-19 Vaccine (But There’s a Catch) Novavax, Inc. (NVAX) dropped an 8-K filing on May 19, 2025, and it’s...
Intellia’s Nex-z Shines in Two-Year Follow-Up: A One-Time CRISPR Cure Getting Closer? Intellia Therapeutics just dropped their 8-K on May 19, 2025, and it’s packed...
Sunnova Extends Forbearance Again: Still Walking a Financial Tightrope Sunnova Energy International Inc. (NOVA) filed an 8-K on May 22, 2025, and let’s just say...
NOV Inc. Showers Shareholders with Dividends After Successful Annual Meeting NOV Inc. (NOV) recently filed an 8-K form on May 22, 2025, detailing the results...
Novagold Shareholders Speak: All Aboard (Mostly) for 2025! Novagold Resources Inc. (NG) recently filed an 8-K on May 20, 2025, detailing the happenings at their...
nCino’s Q1 2026: Preliminary Results Beat Expectations, Investor Day Incoming! nCino, Inc. (NCNO) filed an 8-K on May 20, 2025, and we’re here to decode...
Neurocrine Biosciences Gets Shareholder Nod: Full Steam Ahead? Neurocrine Biosciences, Inc. (NBIX) recently filed an 8-K on May 22, 2025, detailing the outcomes of their...
Mullen Automotive’s Latest SEC Filings: From Revenue Surge to Going Concern Warning – A Story of Extremes Mullen Automotive, Inc. (MULN) filed an 8-K on...
